![]() |
市場調查報告書
商品編碼
1722881
骨整合植入物市場報告:2025 年至 2033 年按產品、材料、最終用戶和地區分類的規模、佔有率、趨勢和預測Osseointegration Implants Market Report Size, Share, Trends and Forecast by Product, Material, End User, and Region, 2025-2033 |
2024 年全球骨整合植入物市場規模價值為 71.1418 億美元。展望未來, IMARC Group估計到 2033 年該市場規模將達到 113.4232 億美元,2025 年至 2033 年的複合年成長率為 5.05%。北美目前佔據市場主導地位,2024 年的市佔率將超過 55.8%。市場主要受到人口老化加劇、牙科和骨科手術需求增加、植入技術進步、口腔健康意識增強、醫療保健基礎設施擴大以及優惠報銷政策實施的推動。
骨科和牙科疾病的盛行率不斷上升,需要先進的植入解決方案才能有效治療,這推動了全球骨整合植入物市場的發展。除此之外,致命道路交通事故的增加以及患有骨關節炎和類風濕性關節炎的人數的增加增加了對關節和膝關節置換手術的需求。這導致消費者對微創手術(MIS)的偏好日益增加,進而推動了市場的成長。除此之外,與改善耐用性、生物相容性和功能性的治療相關的成長和創新正在推動市場的發展。例如,2024 年 3 月 28 日,Osstem Implant 推出了其 TSIII SOI 植入物,該植入物採用下一代超級骨整合 (SOI) 表面處理,可改善癒合並加強初始骨形成。這種新的表面處理方法使用紫外線和 HEPES 緩衝劑來創建超親水塗層,可增強生物相容性並將骨整合期從長達六個月縮短至約兩個月。此外,醫療保健支出的增加、政府的支持政策以及微創手術技術的採用的成長也促進了骨整合植入物在已開發市場和新興市場的大規模滲透。
美國市場主要受到運動相關損傷和創傷病例日益增多的影響,這些病例需要先進的植入解決方案來進行復健和恢復。糖尿病和血管疾病等慢性病的發生率不斷上升,常常導致截肢,從而推動了對骨整合義肢系統的需求。此外,完善的醫療保健基礎設施和強力的報銷政策促進了醫療保健提供者和患者採用這些先進的植入物。此外,對整容和重建手術的需求不斷成長,特別是尋求功能和美學增強的個人,也促進了市場的成長。除此之外,美國醫療器材製造商所進行的廣泛研發活動以及該國骨整合植入技術的創新。例如,2024 年 9 月 9 日,SINTX Technologies 收到了美國專利商標局 (USPTO) 專利的授權通知,該專利涵蓋將生物活性氮化矽黏合到氧化鋯增韌氧化鋁 (ZTA) 表面的方法。該公司繼續擴大其智慧財產權組合,目前擁有 16 項美國專利。
骨骼相關疾病的盛行率不斷上升
骨關節炎、骨質疏鬆症和先天性異常等骨骼疾病的發生率不斷增加,是使用骨整合植入物的因素。全球老齡人口不斷成長,增加了使用骨整合過程進行外科手術的需求,特別是在牙科和矯形義肢方面。對於人口結構中老年人口較多的已開發市場而言,其需求日益強烈。世界衛生組織估計,2019 年全球約有 5.28 億人患有骨關節炎,比 1990 年增加了 113%。此外,73% 的骨關節炎患者年齡在 55 歲及以上。此外,其中60%為女性。因此,老年族群中骨關節炎盛行率的上升推高了對骨整合植入物的需求,因為大多數患者都需要進行關節置換等手術。因此,由於人口老化和骨骼疾病的增多,骨整合植入物市場正在大幅成長。
技術進步
植入物表面的材料、塗層和技術的創新正在徹底改變骨整合植入物的功效和效率。鈦及其合金等生物相容性材料的開發進一步推動了市場的成長,這些材料確保了此類植入物具有更高的成功率,並為患者帶來了耐用性和舒適性。此外,新的 3D 列印技術提供了創建客製化植入物的可能性,從而改善治療效果和患者滿意度。這些創新增加了醫療服務提供者對骨整合植入物的接受度,並簡化了骨整合植入物的可近性和成本。 Keystone Dental Holdings 於 2023 年 11 月推出了 GENESIS ACTIVE 種植系統。這種創新的例子就是新型 GENESIS ACTIVE 植牙系統的進步,Keystone Dental Holdings 於 2023 年 11 月宣布推出該系統。這種牙科植牙手術解決方案推動了該行業的植入和修復技術的發展。持續的技術進步正在改善患者的治療效果,同時使整個植入過程更加高效,並推動骨整合植入物市場的成長。
美容和功能性植入物需求不斷成長
將功能優勢與美觀相結合的植入物的需求不斷成長,尤其是在牙科應用中,這成為骨整合市場的重要成長動力。骨整合植體可以永久、自然地取代缺失的牙齒,兼具功能和美觀的優勢。這使得它們在希望改善生活品質的患者中非常受歡迎,主要原因是各地區醫療保健服務可近性和意識的提高。 2024年,世界衛生組織口腔健康報告持續反映口腔健康問題在全球持續存在。據估計,全球約有 20 億人患有恆牙齲齒,約有 5.14 億兒童患有乳牙齲齒,他們對骨整合植入物等更好的牙科解決方案的需求持續巨大。對先進牙科護理日益成長的需求是全球骨整合植入物市場擴張的重要驅動力。
The global osseointegration implants market size was valued at USD 7,114.18 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 11,342.32 Million by 2033, exhibiting a CAGR of 5.05% from 2025-2033. North America currently dominates the market, holding a market share of over 55.8% in 2024. The market is primarily driven by the increasing aging populations, rising demand for dental and orthopedic procedures, advancements in implant technologies, growing awareness about oral health, expanding healthcare infrastructure, and the implementation of favorable reimbursement policies.
The increasing prevalence of orthopedic and dental disorders, which require advanced implant solutions for effective treatment, is driving the global osseointegration implants market. In addition to this, the increasing number of fatal road traffic accidents and the growing number of individuals suffering from osteoarthritis and rheumatoid arthritis increases the need for joint and knee replacement surgeries. This leads to increasing consumer preferences for minimally invasive surgeries (MIS), which is propelling the growth of the market. Besides this, growth and innovations related to treatments improving durability, biocompatibility, and functionality, are fueling the market development. For instance, on March 28, 2024, Osstem Implant launched its TSIII SOI implant which boasts of the next-generation Super Osseointegration (SOI) surface treatment that improves healing and strengthens initial bone formation. This new surface treatment uses UV and HEPES buffering agents to create a super-hydrophilic coating that enhances biocompatibility and reduces the osseointegration period from up to six months to about two months. Apart from this, it is supported by the increasing healthcare expenditure, supportive government policies, and the growth in the adoption of minimally invasive surgical techniques for promoting the mass penetration of osseointegration implants in the developed and emerging markets.
The market in the United States is majorly influenced by the growing prevalence of sports-related injuries and trauma cases, which demand advanced implant solutions for rehabilitation and recovery. The rising incidence of chronic conditions like diabetes and vascular diseases, often leading to limb amputations, drives the demand for osseointegrated prosthetic systems. Moreover, a well-established healthcare infrastructure and strong reimbursement policies promote the adoption of these advanced implants among healthcare providers and patients. Additionally, the rising demand for cosmetic and reconstructive surgeries, particularly among individuals seeking functional and aesthetic enhancements, contributes to market growth. Besides this, the extensive research and development (R&D) activities undertaken by U.S.-based medical device manufacturers and the innovation of osseointegration implant technologies in the country. For example, on September 9, 2024, SINTX Technologies received a notice of allowance for a USPTO patent covering methods to bond bioactive silicon nitride to zirconia-toughened alumina (ZTA) surfaces. The company continues to grow its intellectual property portfolio, now holding 16 U.S. patents.
Growing Prevalence of Bone-related Disorders
Increasing incidences of bone conditions such as osteoarthritis, osteoporosis, and congenital anomalies are contributing factors to the use of osseointegration implants. An ever-growing elderly global population increases the desire for surgical operations using osseointegration processes, especially on dental and orthopedic prosthetics. There is an intensified demand for developed markets that account for older populations in their demographic groups. The World Health Organization estimates that around 528 million people across the globe were living with osteoarthritis in 2019, a 113% increase from 1990. In addition, 73% of individuals with osteoarthritis are aged 55 years and above. Moreover, 60% of these individuals are women. As a result, this increased prevalence of osteoarthritis among the elderly population is driving up the need for osseointegration implants since most of these patients require procedures like joint replacements. Thus, the osseointegration implants market is growing considerably due to an ageing population and a growing number of bone disorders.
Technological Advancements
Innovations in the materials, coatings, and techniques of implant surface are revolutionizing the efficacy and efficiency of osseointegration implants. Growth in the market is further fueled by the development of biocompatible materials, including titanium and its alloys, that ensure higher success rates for such implants, with patients experiencing durability and comfort. Also, the new 3D printing technologies are offering the possibility to create customized implants, thus bettering outcomes and patient satisfaction. These innovations increase osseointegration implant uptake by healthcare service providers and ease accessibility as well as their cost. Keystone Dental Holdings rolled out the GENESIS ACTIVE Implant System during November 2023. An example of such innovation is seen with the advancement of the new GENESIS ACTIVE Implant System, with Keystone Dental Holdings announcing it in November 2023. This dental implant surgical solution advances placement and restoration for the sector. Continued technological advancements are improving patient outcomes while making the overall process of implant procedures more efficient, and it is driving growth in the osseointegration implants market.
Rising Demand for Aesthetic and Functional Implants
The growing demand for implants that integrate functional advantages with aesthetic enhancement, especially in dental application, acts as a significant growth driver for the osseointegration market. Osseo integration implants provide a permanent and natural replacement of missing teeth that provides both functional and aesthetic advantages. This makes them highly in need among patients looking forward to improving the quality of their life, mainly driven by improving access and awareness in healthcare across the regions. In 2024, the World Health Organization report on oral health continues to reflect that oral health issues persist in the global scene. Estimated to have reached several about 2 billion, people suffering from caries in permanent teeth, and approximately 514 million children with caries in primary teeth, continue to present such immense demands for better dental solutions such as osseointegration implants. This growing demand for advanced dental care is a significant driving force behind the expansion of the osseointegration implants market across the world.
Bone-anchored prostheses lead the market in 2024. Bone-anchored prostheses are considered a revolutionary solution for those individuals requiring limb replacement or rehabilitation. The advanced nature of these prosthetic products makes use of osseointegration technology, which involves the direct integration of an implant with bone tissue, thereby offering stability, functionality, and comfort more than socket-based prosthetics. Their growing adoption is due to the increasing prevalence of amputations due to trauma, diabetes, and vascular diseases, coupled with rising awareness about advanced prosthetic options. Users in developed as well as developing markets witness high demand as bone-anchored prostheses can enhance their movement, diminish their pain and even improve the quality of their lives. Besides, the continuous development of implant materials and surgical procedures further enhances their market potential, which makes bone-anchored prostheses a significant product in the osseointegration implant market.
Metallic leads the market with around 63.5% of market share in 2024. Metallic materials are the mainstay of growth in the global osseointegration implants market, as they have excellent biocompatibility, durability, and mechanical strength. The most widely used metals, such as titanium and its alloys, are preferred for their osseointegration capability, especially for establishing a stable bonding with the bone tissue. These materials are resistant to corrosion and wear, which ensures the long-term functionality and reliability of implants used in dental, orthopedic, and maxillofacial applications. The growing need for durable, high-performance implants, especially for the aging population and for patients with trauma or degenerative conditions, gives vital significance to metallic materials in this market. Moreover, novel techniques in metal fabrication, for example, 3D printing and surface coating technologies, positively impact implant customization while further enhancing patient benefits.
Hospitals lead the market with around 65.9% of market share in 2024 due to the extensive provision of different types of medical services and surgical procedures that are provided for patients seeking proper care. Hospitals have an enormous client base with various types of patients in need of osseointegration implants. Patients may suffer from orthopedic, dental, or maxillofacial disorders and could be survivors of trauma and cancer requiring reconstruction solutions. A growth in surgeries combined with hospital admission due to the prevalence of conditions requiring implantation augments the demand for osseointegration implants. In addition to this, government and private investments in hospital facilities, especially in emerging economies, increase access to quality care, which in turn propels the growth of the market. Hospitals' ability to provide complete post-operative care and rehabilitation ensures optimal patient outcomes, which further strengthens their role in the expansion of the osseointegration implant market.
In 2024, North America accounted for the largest market share of over 55.8% due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a well-established regulatory framework. The increasing elderly population in the region and rising cases of trauma, osteoporosis, and dental conditions significantly fuel the demand for osseointegration implants. Countries like the United States and Canada have huge healthcare spending, strong reimbursement policies, and a strong presence of leading industry players, which fosters rapid adoption of advanced implants. Additionally, research and development (R&D) activities are further supported by funding from the government as well as the private sector to enhance product innovation and patient outcomes. With an increase in awareness regarding the advantages of osseointegration and a large percentage of the population suffering from chronic conditions requiring implants, North America is an essential contributor to the growth of the market. Its proactive attitude toward the adoption of cutting-edge medical solutions ensures sustained importance in the global market.
United States Osseointegration Implants Market Analysis
The United States is a significant region in the osseointegration implants market with the market share of 89.30%, due to the rise in the number of people with arthritis and mobility problems. According to the CDC, a report in 2024 stated that about 58.5 million adults aged 18 years and older are living with arthritis in the United States, with 25.7 million experiencing activity limitations due to arthritis. The projections indicate that, by 2040, this number will surge to 78 million adults, and this population is surely aged, attributed also to lifestyle, in musculoskeletal conditions. Arthritis is a primary cause of disability and surely does require surgical intervention like joint replacements, where osseointegration implants improve mobility and quality of life. Growing demand for advanced implants made from biocompatible materials, along with the increasing awareness of healthcare, is driving the growth of the market. In addition, efforts to increase access to orthopedic care are expected to boost the demand for osseointegration solutions in the United States.
Europe Osseointegration Implants Market Analysis
The Europe osseointegration market is expected to rise significantly due to the aging population in the region and the rise in osteoporosis. On January 1, 2023, the European Union population was 448.8 million, with one-fifth, or 21.3%, aged 65 years or above, according to the European Commission. This indicates the growing needs for medical interventions, such as osseointegration implants, to treat the bone-related condition associated with advancing age. Additionally, osteoporosis remains a serious health issue in Europe, where over 23 million people are at high risk of osteoporotic fractures, as NIH data in 2021 indicates. The majority of such fractures require surgery and implantation, which means the demand for more advanced osseointegration technologies is increased. Moreover, solid healthcare infrastructure combined with innovations happening in implantable materials and surgical techniques increase the success ratio of treatments for osseointegration, giving Europe a large market for its solutions.
Asia Pacific Osseointegration Implants Market Analysis
The Asia Pacific osseointegration implants market has high growth potential, as the region has a rapidly aging population and is witnessing rising osteomyelitis, among other bone-related disorders. According to NIH, the population aged 65 or older in China will grow more than double from 172 million or 12.0% of total population in 2020 to 366 million or 26.0% by 2050. This demographic change gives rise to increasing demand for state-of-the-art healthcare services. This encompasses conditions such as osteoporosis, arthritis, and joint degeneration, in addition to osseointegration implants. Also, the healthcare infrastructure is becoming more advanced within the region. There are enhanced investments in the medical technology space, thus paving the way for growth. It includes Japan-one of the most geriatric countries and India- one of the increasing healthcare conscious ones. Advances in implant materials, including personalized 3D printing of implants, improve success rates. Therefore, osseointegration implants are witnessing significant growth as the leading market area in the Asia Pacific region.
Latin America Osseointegration Implants Market Analysis
The Latin American osseointegration implants market is growing due to the increasing orthopedic disorder prevalence, primarily in Brazil. In this region, the growing demand for hip replacement surgeries supports the market expansion. According to estimates from the Brazilian Hip Society, there are about 70,000 hip arthroplasties performed annually. Only 17,000 of them are publicly funded, according to an NCBI report in 2020. Thus, this situation presents a sizeable opportunity for private healthcare service providers to help bridge the ever-growing demand gap for hip replacement and osseointegration implants. The aging population in Latin America and the rising awareness of advanced medical technologies are also contributing to the need for high-quality orthopedic implants. As more patients seek personalized and long-lasting solutions for conditions like osteoarthritis and osteoporosis, the market for osseointegration implants in Latin America is expected to continue its growth. The region is heading for tremendous gains in implant technology and patient care, thus offering some great opportunities that are expected in the coming years.
Middle East and Africa Osseointegration Implants Market Analysis
The Middle East and Africa (MEA) osseointegration implants market is witnessing significant growth with the increasing incidence of bone-related disorders like osteoarthritis (OA) and rising investments in healthcare. According to the NIH, the standardized prevalence of OA in the MENA region was 5,342.8 cases per 100,000 in 2019. This number rose by 9.3% from 1990. The growing case of OA, which is greatly promoted through the aging population, fuels the need for joint replacement surgeries, a scenario where osseointegration implants are fundamental. Additional strength to the increased demand for superior medical technologies that include osseointegration implants is provided with the increasing regional healthcare spending-estimated to stand at USD 135.5 Billion by the year 2027 in GCC, as per reports. Moreover, the rising preference and adoption of innovative and highly biocompatible materials in solutions from implant technology, which is currently enhancing the whole market growth through the MEA region.
The osseointegration implants market at the global level is highly competitive, with key manufacturers focusing on innovation, technology, and differentiation in products. The key companies majorly emphasize the research and development (R&D) activities of implant design, biocompatibility, and long-term durability. Companies have been investing significantly in minimally invasive solutions and personalized implants in order to bring better patient results. Market players are trying to increase their geographies through partnerships, collaboration, and distribution agreements. Rising consumption of advanced materials such as titanium and ceramic help in further innovation. Manufacturers target emerging markets by providing cost-effective solutions, which impact the market dynamics.